- Free from Publisher L Tarnow, P Hovind, T Teerlink, CDA … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—In patients with diabetic nephropathy, mean ± SD plasma ADMA
concentration was elevated 0.46 ± 0.08 vs. 0.40 ± 0.08 μmol/l in
normoalbuminuric patients (P < 0.001). An increase in plasma ADMA of 0.1 ... Cited by 88 - Related articles - BL Direct - All 5 versions
- ►asnjournals.org P Ravani, G Tripepi, F Malberti, S Testa, F … - Journal of the American Society of Nephrology, 2005 - Am Soc Nephrol High plasma asymmetrical dimethylarginine (ADMA) signals endothelial dysfunction
and atherosclerosis in the general population and predicts mortality in ESRD.
The relationship among plasma levels of ADMA, renal function, and the risk ... Cited by 127 - Related articles - BL Direct - All 8 versions
H Päivä, T Lehtimäki, J Laakso, I Ruokonen, … - Metabolism, clinical and experimental, 2003 - cat.inist.fr Asymmetric dimethylarginine(ADMA) is an endogenous inhibitor of nitric oxide
synthase(NOS). Increased plasma levels of ADMA may indicate endothelial
dysfunction and increased risk of angiopathy. The relation of ADMA to ... Cited by 51 - Related articles - BL Direct - All 11 versions
- ►asnjournals.org D Fliser, F Kronenberg, JT Kielstein, C … - Journal of the American Society of Nephrology, 2005 - Am Soc Nephrol Reduced bioavailability of nitric oxide (NO) is thought to play an important
role in progression of renal damage. The hypothesis that the endogenous NO
synthase inhibitor asymmetric dimethylarginine (ADMA) is involved in ... Cited by 96 - Related articles - BL Direct - All 10 versions
- ►endojournals.org AE Altinova, M Arslan, A Sepici-Dincel, M … - Journal of Clinical Endocrinology & Metabolism, 2007 - Endocrine Soc Results: Plasma ADMA concentrations were higher (2.6 ± 1.9 vs. 1.7 ± 0.7
µmol/liter, P < 0.01), and L-arginine levels were lower (79.3 ± 22.6 vs. 89.6
± 19.4 µmol/liter, P < 0.05) in the diabetic group, compared with ... Cited by 14 - Related articles - BL Direct - All 4 versions
- ►asnjournals.org K Matsuguma, S Ueda, S Yamagishi, Y … - Journal of the American Society of Nephrology, 2006 - Am Soc Nephrol Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide
synthase. ADMA is generated by protein methyltransferase (PRMT) and is
metabolized mainly by dimethylarginine dimethylaminohydrolase (DDAH). ADMA ... Cited by 41 - Related articles - All 6 versions
- ►ahajournals.org V Achan, M Broadhead, M Malaki, G Whitley, J … - Arteriosclerosis, thrombosis, and vascular biology, 2003 - Am Heart Assoc Methods and Results— In a randomized, double-blind, placebo-controlled study
in 12 healthy male volunteers, we compared the effects of intravenous low-dose
ADMA and placebo on heart rate, blood pressure, cardiac output, and ... Cited by 240 - Related articles - BL Direct - All 7 versions
N Chan, J Chan - Diabetologia, 2002 - Springer Endothelium-derived nitric oxide plays a major role in the regulation of
vascular tone and in the maintenance of vascular homeostasis. Endothelial
dysfunction with impaired nitric oxide biosynthesis and decreased bio- ... Cited by 65 - Related articles - BL Direct - All 5 versions
- ►asnjournals.org JT Kielstein, RH Boger, SM Bode-Boger, JC … - Journal of the American Society of Nephrology, 2002 - Am Soc Nephrol ABSTRACT. In patients with uremia, increased blood concentrations of the
endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA)
have been linked to the severity of atherosclerosis and to excess ... Cited by 182 - Related articles - BL Direct - All 15 versions
K Caglar, MI Yilmaz, A Sonmez, E Cakir, A Kaya … - Kidney international, 2006 - nature.com The rationale of this study is based on the fact that, both proteinuria and
elevated asymmetric dimethyl arginine (ADMA) levels have been linked to the
progression of vascular disease. Currently, there is not enough knowledge ... Cited by 39 - Related articles - BL Direct - All 6 versions
